PROCEPT BioRobotics (PRCT) Other Accumulated Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Other Accumulated Expenses for 7 consecutive years, with $10.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 20.88% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 20.88% YoY), while the FY2025 annual figure was $10.1 million, up 24.53% from the prior year.
• Other Accumulated Expenses rose to $10.2 million in Q1 2026 per PRCT's latest filing, from $10.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $10.2 million in Q1 2026 and bottomed at $4.0 million in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $7.7 million across 5 years, with a median of $7.8 million in 2023.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 109.21% — and 2023, when it decreased 15.4%.
• PROCEPT BioRobotics' Other Accumulated Expenses stood at $7.5 million in 2022, then fell by 15.4% to $6.3 million in 2023, then climbed by 28.03% to $8.1 million in 2024, then grew by 24.53% to $10.1 million in 2025, then climbed by 1.75% to $10.2 million in 2026.
• Business Quant data shows PRCT's Other Accumulated Expenses at $10.2 million in Q1 2026, $10.1 million in Q4 2025, and $8.2 million in Q3 2025.